fbpx
QQQ
+ 7.05
312.29
+ 2.21%
DIA
+ 4.00
336.23
+ 1.18%
SPY
+ 6.32
403.85
+ 1.54%
TLT
+ 1.27
134.54
+ 0.94%
GLD
+ 1.54
169.61
+ 0.9%

Ikänik Farms Exports Pharma Grade Cannabis To Mexico For COVID Study

July 20, 2020 2:58 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Ikänik Farms Exports Pharma Grade Cannabis To Mexico For COVID Study

California-based Ikänik Farms Inc. has partnered with CAS Biotechnology to study the effects of pharmaceutical-grade cannabis oil in the treatment of COVID-19.

Under the collaboration deal, Ikänik opted to export the pharmaceutical-grade cannabis provided by its Colombia-based GACP and GMP-Pharma certified Casa Flores facility to Mexico.

The company said Monday that CAS Biotechnology's team would be responsible for testing samples provided by Pideka SAS.

The Mexico-based CAS Biotechnology will oversee scientific research and pre-clinical trials to evaluate the effect of Cannabis oil on SARS-CoV-2's replication cycle.

Ikänik International's President Borja Sanz de Madrid is thrilled with the new partnership while hoping to "aid in the treatment of COVID-19."

"We are very proud to participate in a study that brings medicine and cannabis closer together, in a joint effort to discover possible Phyto therapeutic treatments, as a new course of action for the treatment of COVID-19," Ikänik CEO Brian Baca said. 

Earlier this month, the company acquired Delta 9 Corporation Mexico in order to export hemp and cannabis products to Mexico legally.

Posted-In:

Cannabis News

Related Articles

Why The U.S. Cannabis Industry Is Better Positioned Than Canada To Go National

By Lauri Kibby of Kings Garden. Cannabis industry optimism in the United States is mounting alongside increasing expectations for national legalization. read more

Boston Beer Company To Develop Non-Alcoholic Cannabis Beverages

The Boston Beer Company Inc (NYSE: SAM) is creating a Canadian-based subsidiary focusing on research and development of non-alcoholic  cannabis beverages. read more

Vireo Q1 Revenue Increases 9% YoY, Reports Improvement In Gross Margin

Vireo Health International, Inc. (CSE: VREO) (OTCQX: VREOF), a science-focused, multistate cannabis company, reported its financial results for the first quarter of 2021 on Friday. read more

Supreme Cannabis Q3 Revenue Plunges Ahead Of Merger With Canopy Growth

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) reported Thursday having earned $16.8 million in gross revenue in the third quarter of 2021, representing a sequential decrease of 22.5%. read more